Coinfection with @entity461 and @entity2718 after use of XXXX .

@entity1 @entity868 @entity17313 @entity294 @entity391 @entity1960 @entity281 @entity158 @entity461 @entity5616 @entity2718
A 49-year-old @entity1 presented with a 3-week history of @entity391 and @entity294 . He reported foamy stools but no blood or melena and had crampy @entity158 . He denied usage of antibiotics. He had been taking @entity5616 for intermittent @entity158 for the last few months and noted an 11-pound weight loss during the 3 weeks before admission. Stool was positive for @entity2718 toxin and Giardia lamblia antigen. Cultures and occult blood tests were negative. Oral @entity868 , 500 mg 3 times a day, was administered, and the @entity1 was hydrated. The @entity294 resolved, and @entity1 was discharged on the fourth hospital day. Prior antibiotic therapy is the most common risk factor for @entity2718 @entity1960 . This @entity1 developed concomitant infection with @entity2718 and @entity461 while he used @entity5616 . He had no other risk factors for these infections. Hence, we propose that @entity5616 -induced @entity17313 predisposed this @entity1 to the @entity281 .
